From an investment perspective, Propanc offers a striking contrast to the high-valuation tech stocks now under rotation pressure. With a market capitalization under $15 million, it trades at a ...

Presentations showcase the power of omnimodal profiling to identify predictive immune signatures, comprehensively profile the tumor microenvironment and reveal novel therapeutic targets for optimized ...

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...

Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and ...

This article is presented by EFPIA with the support of AbbVie I made a trip back to Europe recently, where I spent the vast ...

Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date ...

A new report by Treatment Action Group (TAG) warns that a key ingredient in several vaccines of global health importance may face critical supply bottlenecks in the coming years unless governments, ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...

Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date wo ...

A research team at Duke University has developed a new AI framework that can uncover simple, understandable rules that govern ...

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can precisely ...